Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1

Status

Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 3Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 17Myelodysplastic Syndromes 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Hematologic Neoplasms 9Myeloproliferative Disorders 8Multiple Myeloma 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Leukemia, Lymphocytic, Chronic, B-Cell 8Hodgkin Disease 7Lymphoma, Non-Hodgkin 6Graft vs Host Disease 6Waldenstrom Macroglobulinemia 5Lymphoma 5Burkitt Lymphoma 5Recurrence 4Primary Myelofibrosis 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasms 4Lymphoma, Mantle-Cell 4Leukemia, Prolymphocytic 4Leukemia, Myelomonocytic, Chronic 4Skin Neoplasms 3Sarcoma 3Rhabdomyosarcoma 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Biphenotypic, Acute 3Leukemia 3Bronchiolitis Obliterans Syndrome 3

Interventions

pembrolizumab 16Nivolumab 15Ipilimumab 12cemiplimab 10aldesleukin 6Interleukin-2 6Cyclophosphamide 6fludarabine 5fludarabine phosphate 4encorafenib 4binimetinib 4Blood Specimen Collection 4avelumab 3Sirolimus 3trametinib 2spartalizumab 2lifileucel 2dabrafenib 2atezolizumab 2Vemurafenib 2Surgical Procedures, Operative 2Specimen Handling 2Radiotherapy 2Prednisone 2Niacinamide 2Exercise 2Everolimus 2Dermoscopy 2Biopsy 2urelumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Skin Neoplasms × Sirolimus × 1 year × Clear all
NCT07426484 2026-02-23

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

Dana-Farber Cancer Institute

Phase 4 Not yet recruiting
80 enrolled
DermatologicLymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Waldenstrom Macroglobulinemia, Skin Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasms, Plasma Cell

NCT00133887 2025-12-26

TUMORAPA 1: Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant Recipients

Hospices Civils de Lyon

Phase 3 Completed
77 enrolled
Dermatologic

Carcinoma, Squamous Cell, Skin Neoplasms

NCT05860881 2025-09-09

SiroSkin

Melanoma and Skin Cancer Trials Limited

Phase 3 Active not recruiting
146 enrolled
Dermatologic

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡